Alliance Pharma Share Price | |
---|---|
Price | 34.90 |
Bid | 34.80 |
Ask | 35.15 |
Change | -0.10 (-0.29%) |
Volume | 4,075,925 |
Open | 35.00 |
High | 35.20 |
Low | 34.25 |
Prev. Close | 35.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £188.60m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 220 |
---|---|
Vol. Sold | 1,163,184 |
Sold Value | £402.43k |
Vol. Bought | 1,804,373 |
Bought Value | £630.28k |
PE Ratio | 205.29412 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.845% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
25-Apr-24 | 17:52:30 | 34.90 | 3,261 | Unknown* | 34.80 | 35.15 | 1,138 | O Ordinary Was reported as OTC |
25-Apr-24 | 17:45:19 | 34.901 | 4,212 | Unknown* | 34.80 | 35.15 | 1,470 | O Ordinary Was reported as OTC |
25-Apr-24 | 17:42:56 | 34.972 | 29,469 | Unknown* | 34.80 | 35.15 | 10.31k | O Ordinary Was reported as OTC |
25-Apr-24 | 17:32:10 | 34.85 | 147,970 | Unknown* | 34.80 | 35.15 | 51.57k | O Ordinary Was reported as OTC |
25-Apr-24 | 16:35:28 | 34.90 | 34,082 | Sell* | 34.90 | 35.25 | 11.89k | UT Uncrossing Trade |
25-Apr-24 | 16:29:55 | 34.80 | 51 | Sell* | 34.80 | 35.10 | 17.75 | A Automatic Execution |
25-Apr-24 | 16:29:55 | 34.80 | 1 | Sell* | 34.80 | 35.10 | 0.35 | A Automatic Execution |
25-Apr-24 | 16:22:33 | 35.00 | 910 | Buy* | 34.85 | 35.00 | 318.50 | A Automatic Execution |
25-Apr-24 | 16:22:33 | 35.00 | 304 | Buy* | 34.85 | 35.00 | 106.40 | A Automatic Execution |
25-Apr-24 | 16:22:30 | 34.95 | 32 | Buy* | 34.85 | 34.95 | 11.18 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions